Xianwei Wang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Xianwei Wang has a total of 21 co-authors. Here are the top co-authors by number of shared publications:
Jiaming Huang
5 shared publicationsDong Chen
Department of Neurosurgery, Central Hospital Affiliated to Dalian University of Technology (Dalian Central Hospital)
4 shared publicationsMei Li
3 shared publicationsTao Jiang
Dalian Univ Technol, Affiliated Cent Hosp, Dalian, Peoples R China
3 shared publicationsHaoran Zhang
2 shared publicationsLiding Wang
Dalian University of Technology, China
2 shared publications
Latest Publications
- Open Access
- 1 July 2026
- Published by Frontiers Media SA in Frontiers in Surgery
- Vol. 13, 1837432
Case Report: Carotid body paraganglioma in a 20-year-old woman: multimodal imaging, vessel-preserving surgical excision, and long-term clinical follow-up
Carotid body paraganglioma is a rare hypervascular neuroendocrine tumor of the head and neck, and presentation in a 20-year-old woman is uncommon. We report a young woman with a painless left lateral neck mass present for more than 5 years, with more noticeable enlargement during the preceding year. On admission, a firm, mobile, non-tender mass was palpated along the anterior border of the left sternocleidomastoid muscle, without an audible bruit. Initial and targeted ultrasonography demonstrated a hypervascular lesion centered at the left carotid bifurcation. Preoperative contrast-enhanced computed tomography angiography (CTA) demonstrated a hypervascular mass centered at the left carotid bifurcation with widening of the bifurcation and separation of the internal and external carotid arteries; magnetic resonance imaging (MRI) showed a heterogeneously enhancing carotid-space mass with internal flow-void foci; and digital subtraction angiography (DSA) confirmed marked tumor blush, collectively supporting the diagnosis of carotid body paraganglioma. Surgical excision was performed under general anesthesia. Intraoperatively, the tumor crossed the carotid bifurcation, wrapped around the internal and external carotid arteries, and was extremely vascular; however, grossly complete, vessel-preserving excision was achieved with preservation of the carotid arteries, hypoglossal nerve, and vagus nerve. Histopathology confirmed carotid body paraganglioma with an organoid/nested architecture within a rich vascular stroma and immunohistochemistry showing synaptophysin (Syn)(+), chromogranin A (CgA)(+), S-100(+), and a Ki-67 labeling index of approximately 5%; the original pathology report did not specify a formal microscopic margin status. Balloon occlusion testing, biochemical catecholamine work-up, functional imaging, and genetic testing were not documented in the available record. The postoperative course was uneventful. Ultrasonographic follow-up on July 26, 2018 showed no definite recurrent lesion or obvious vascular abnormality, and long-term clinical follow-up by telephone revealed no recurrence-related symptoms, although no further imaging surveillance was available, and asymptomatic radiologic recurrence cannot be fully excluded. This case highlights the value of multimodal imaging in diagnosis and operative planning and shows that grossly complete, vessel-preserving excision can be associated with favorable short-term imaging and long-term symptom-based follow-up findings in a young patient.
- 1 July 2026
- Published by Frontiers Media SA in Frontiers in Surgery
- Vol. 13, 1837432
Open AccessCase Report: Carotid body paraganglioma in a 20-year-old woman: multimodal imaging, vessel-preserving surgical excision, and long-term clinical follow-up
Carotid body paraganglioma is a rare hypervascular neuroendocrine tumor of the head and neck, and presentation in a 20-year-old woman is uncommon. We report a young woman with a painless left lateral neck mass present for more than 5 years, with more noticeable enlargement during the preceding year. On admission, a firm, mobile, non-tender mass was palpated along the anterior border of the left sternocleidomastoid muscle, without an audible bruit. Initial and targeted ultrasonography demonstrated a hypervascular lesion centered at the left carotid bifurcation. Preoperative contrast-enhanced computed tomography angiography (CTA) demonstrated a hypervascular mass centered at the left carotid bifurcation with widening of the bifurcation and separation of the internal and external carotid arteries; magnetic resonance imaging (MRI) showed a heterogeneously enhancing carotid-space mass with internal flow-void foci; and digital subtraction angiography (DSA) confirmed marked tumor blush, collectively supporting the diagnosis of carotid body paraganglioma. Surgical excision was performed under general anesthesia. Intraoperatively, the tumor crossed the carotid bifurcation, wrapped around the internal and external carotid arteries, and was extremely vascular; however, grossly complete, vessel-preserving excision was achieved with preservation of the carotid arteries, hypoglossal nerve, and vagus nerve. Histopathology confirmed carotid body paraganglioma with an organoid/nested architecture within a rich vascular stroma and immunohistochemistry showing synaptophysin (Syn)(+), chromogranin A (CgA)(+), S-100(+), and a Ki-67 labeling index of approximately 5%; the original pathology report did not specify a formal microscopic margin status. Balloon occlusion testing, biochemical catecholamine work-up, functional imaging, and genetic testing were not documented in the available record. The postoperative course was uneventful. Ultrasonographic follow-up on July 26, 2018 showed no definite recurrent lesion or obvious vascular abnormality, and long-term clinical follow-up by telephone revealed no recurrence-related symptoms, although no further imaging surveillance was available, and asymptomatic radiologic recurrence cannot be fully excluded. This case highlights the value of multimodal imaging in diagnosis and operative planning and shows that grossly complete, vessel-preserving excision can be associated with favorable short-term imaging and long-term symptom-based follow-up findings in a young patient.
- Open Access
- 18 February 2026
- Published by Elsevier in Atherosclerosis Plus
- Vol. 63, 67-76
Role of abnormal phosphatidylcholine metabolism in endoplasmic reticulum stress-induced carotid artery plaque destabilization
- 18 February 2026
- Published by Elsevier in Atherosclerosis Plus
- Vol. 63, 67-76
Open AccessRole of abnormal phosphatidylcholine metabolism in endoplasmic reticulum stress-induced carotid artery plaque destabilization
- 13 March 2025
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 758, 151619
The experimental study of the effect of fluid shear force on the migration rate of human umbilical vein endothelial cells
- 13 March 2025
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 758, 151619
The experimental study of the effect of fluid shear force on the migration rate of human umbilical vein endothelial cells
- Open Access
- 2 December 2024
- Published by Springer Nature in Discover Oncology
- Vol. 15 (1) , 1-13
Current advances on the role of ferroptosis in tumor immune evasion
Ferroptosis is a non-apoptotic form of regulated cell death characterized by iron accumulation and uncontrolled lipid peroxidation, leading to plasma membrane rupture and intracellular content release. Cancer immunotherapy, especially immune checkpoint inhibitors (ICIs) targeting PD-1 and PD-L1, has been considered a breakthrough in cancer treatment, achieving encouraging clinical anti-tumor effects in a variety of cancers. However, tumor immune evasion is indispensable to immunotherapy failure. The mechanisms of tumor immune evasion are quite complex, and its occurrence is inseparable from the ferroptosis in tumor microenvironment (TME). Thus, a comprehensive understanding of the role of ferroptosis in tumor immune evasion is crucial to enhance the efficacy of immunotherapy. In this review, we provide an overview of the recent advancements in understanding ferroptosis in cancer, covering molecular mechanisms and interactions with the TME. We also summarize the potential applications of ferroptosis induction in immunotherapy, as well as ferroptosis inhibition for cancer treatment in various conditions. We finally discuss ferroptosis as a double-edged sword, including the current challenges and future directions regarding its potential for cancer treatment.
- 2 December 2024
- Published by Springer Nature in Discover Oncology
- Vol. 15 (1) , 1-13
Open AccessCurrent advances on the role of ferroptosis in tumor immune evasion
Ferroptosis is a non-apoptotic form of regulated cell death characterized by iron accumulation and uncontrolled lipid peroxidation, leading to plasma membrane rupture and intracellular content release. Cancer immunotherapy, especially immune checkpoint inhibitors (ICIs) targeting PD-1 and PD-L1, has been considered a breakthrough in cancer treatment, achieving encouraging clinical anti-tumor effects in a variety of cancers. However, tumor immune evasion is indispensable to immunotherapy failure. The mechanisms of tumor immune evasion are quite complex, and its occurrence is inseparable from the ferroptosis in tumor microenvironment (TME). Thus, a comprehensive understanding of the role of ferroptosis in tumor immune evasion is crucial to enhance the efficacy of immunotherapy. In this review, we provide an overview of the recent advancements in understanding ferroptosis in cancer, covering molecular mechanisms and interactions with the TME. We also summarize the potential applications of ferroptosis induction in immunotherapy, as well as ferroptosis inhibition for cancer treatment in various conditions. We finally discuss ferroptosis as a double-edged sword, including the current challenges and future directions regarding its potential for cancer treatment.
- Open Access
- 9 July 2024
- Published by Elsevier in Journal of Stroke and Cerebrovascular Diseases
- Vol. 33 (9) , 107851
Flow shear force destabilizes carotid plaques by affecting CHOP and GRP78 proteins
- 9 July 2024
- Published by Elsevier in Journal of Stroke and Cerebrovascular Diseases
- Vol. 33 (9) , 107851
Open AccessFlow shear force destabilizes carotid plaques by affecting CHOP and GRP78 proteins
- Open Access
- 5 July 2023
- Published by Frontiers Media SA in Frontiers in Neuroscience
- Vol. 17, 1192766
CDC42—A promising immune-related target in glioma
Glioma is the worst prognostic neoplasm in the central nervous system. A polarity-regulating GTPase in cells, known as cell division cycle 42 (CdC42), has been proven to have its overactivation tightly connected to high tumor malignancy. The RNA-seq and protein expression of CDC42 in tumor and comparison tissues were analyzed based on the online tools; CDC42 was remarkably boosted in tumor tissues compared to normal controls. A total of 600 patients in the analysis set from The Cancer Genome Atlas (TCGA) database and 657 patients in the validation set from the Chinese Glioma Genome Atlas (CGGA) database were adopted. The expression of CDC42 in clinical features and biological functions of glioma was analyzed, including differential expression analysis, survival analysis, Gene Ontology (GO), Kyoto Encyclopedia of Genes and Genomes (KEGG) analysis, and immune infiltration analysis. The enrichment of CDC42 was shown to be strongly associated with poor prognosis and terrible clinical indexes of glioma, including higher World Health Organization scale grade, wild-type isocitrate dehydrogenase 1 expression, O6-methylguanine-DNA methyltransferase non-methylated status, and 1p19q non-codeletion status (p < 0.0001). Functional enrichment analysis showed that CDC42 was highly correlated with immune and inflammatory responses in glioma. Additionally, the concentration extent of CDC42 was closely related to immune infiltration, immune checkpoints, and regulatory T (Treg) cell markers (CD4, CD25, and CD127). All evidence suggested that CDC42 may be a potential target for glioma immunotherapy.
- 5 July 2023
- Published by Frontiers Media SA in Frontiers in Neuroscience
- Vol. 17, 1192766
Open AccessCDC42—A promising immune-related target in glioma
Glioma is the worst prognostic neoplasm in the central nervous system. A polarity-regulating GTPase in cells, known as cell division cycle 42 (CdC42), has been proven to have its overactivation tightly connected to high tumor malignancy. The RNA-seq and protein expression of CDC42 in tumor and comparison tissues were analyzed based on the online tools; CDC42 was remarkably boosted in tumor tissues compared to normal controls. A total of 600 patients in the analysis set from The Cancer Genome Atlas (TCGA) database and 657 patients in the validation set from the Chinese Glioma Genome Atlas (CGGA) database were adopted. The expression of CDC42 in clinical features and biological functions of glioma was analyzed, including differential expression analysis, survival analysis, Gene Ontology (GO), Kyoto Encyclopedia of Genes and Genomes (KEGG) analysis, and immune infiltration analysis. The enrichment of CDC42 was shown to be strongly associated with poor prognosis and terrible clinical indexes of glioma, including higher World Health Organization scale grade, wild-type isocitrate dehydrogenase 1 expression, O6-methylguanine-DNA methyltransferase non-methylated status, and 1p19q non-codeletion status (p < 0.0001). Functional enrichment analysis showed that CDC42 was highly correlated with immune and inflammatory responses in glioma. Additionally, the concentration extent of CDC42 was closely related to immune infiltration, immune checkpoints, and regulatory T (Treg) cell markers (CD4, CD25, and CD127). All evidence suggested that CDC42 may be a potential target for glioma immunotherapy.
- 1 January 2022
- Published by Elsevier in Clinical Neurology and Neurosurgery
- Vol. 212, 107067
The relationship with the stability between GRP78, CHOP and human carotid atherosclerotic plaque
- 1 January 2022
- Published by Elsevier in Clinical Neurology and Neurosurgery
- Vol. 212, 107067
The relationship with the stability between GRP78, CHOP and human carotid atherosclerotic plaque